All Articles

A new survey reveals a stunning consensus: 80% of Hill aides want to keep the filibuster. What do these legislative insiders know that the public doesn't?

University tests show Silanna UV's 235nm LEDs eliminate 99.999% of avian flu virus, promising a safe, continuous disinfection tool for farms and public health.

As Halozyme preps for the Evercore conference, we dissect the strategy behind its ENHANZE® royalty engine and new Hypercon™ tech reshaping drug delivery.

A Scottish startup is using magnetic fields from muscles to redefine interaction. Will their MiMiG wristband at CES 2026 make touchscreens obsolete?

A key industrial landlord in Southern California adds a capital allocation expert to its board. Here's why pharma leaders should be paying close attention.

Once a vocal crypto skeptic, Klarna now launches its own stablecoin, aiming to disrupt the $27 trillion payments market with Stripe and a new blockchain.

Gourmia's new all-in-one air fryer promises to do it all for just $60. We look beyond the launch at the strategy and the reality of this holiday deal.

The Canadian real estate giant is selling off office and retail assets to slash debt and double down on residential and industrial properties.

Leidos and Quadridox are merging CT and X-ray diffraction to end baggage screening false alarms. This could mean faster, safer, and less stressful travel.

CytomX heads to key investor conferences with its PROBODY platform. Can promising clinical data and big pharma partnerships overcome recent financial hurdles?

A major forecast predicts modest rate relief for Canadian households but warns of a complex year shaped by US policy, sticky inflation, and tech disruption.

With a new CEO and focused strategy, Prime Medicine faces investors to prove its 'search and replace' gene editor is worth the wait in a crowded field.

A $1.3M deal in Brazil reveals a new trend: investors are skipping risky startups for cash-flowing solar farms, turning green energy into a stable asset.

A Chicago startup's radical battery tech just got a key patent in Saudi Arabia, aiming to build a new EV supply chain and challenge China's dominance.

A new high-frequency report from ADP shows the first weekly job losses in months. Is this a statistical blip or an early warning of an economic slowdown?

Drill results from Etruscus Resources point toward a major copper-gold system under a glacier, adding a new, high-stakes chapter to the Golden Triangle story.

Teva wins key EU approvals for denosumab biosimilars, challenging Amgen's dominance and promising lower costs for osteoporosis and cancer care.

As cyber threats escalate, MSIG USA appoints a new chief to lead its North American expansion. A deep dive into the strategy to capture a booming market.

Keurig Dr Pepper hires a new CFO with a history of major deals, signaling a critical phase in its plan to acquire JDE Peet's and split in two.

Tokyo is betting big on anime and tech, turning its city hall into a giant screen. Is this the future of tourism and the night economy?